ELON TUSK IS GOD

[sonatine]

option up 224%.


hoping for fireworks with amzn tomorrow but im also concerned that everything is priced in.

[Tellafriend]

[Texter]

Goooo CYDY

https://finance.yahoo.com/news/cytod...100010692.html

[Daly]

Goooo CYDY

https://finance.yahoo.com/news/cytod...100010692.html

I don’t claim to understand the science but I trust some folks that I k is that do. This shit is doing things for patients with Rona that Gilead wishes it’s drug did and with zero side effects. This has a shot to go to the moon, like 1.5B company to 50B.

It’s a gamble - like go to the roulette wheel gamble as is all biotech.. want to be clear about that..... but if you got 4000 in chips in your portfolio this might be worth a shot.

[Daly]

Short the market via SPXU (Again) at 15.40.

I think the high is in at 2940. I’ll sell if the market sees 2940.5.

The test will come at 2850. I expect a bounce but expect it break south and if it does we will see 2700.

[sonatine]

btw cant be traded on tos.

[ErickAA]

Goooo CYDY

https://finance.yahoo.com/news/cytod...100010692.html

I don’t claim to understand the science but I trust some folks that I k is that do. This shit is doing things for patients with Rona that Gilead wishes it’s drug did and with zero side effects. This has a shot to go to the moon, like 1.5B company to 50B.

It’s a gamble - like go to the roulette wheel gamble as is all biotech.. want to be clear about that..... but if you got 4000 in chips in your portfolio this might be worth a shot.

I don't see it. The narrative is that the drug is a CCR5 antagonist that blocks HIV from entering cells, and doesn't have serious side effects and can be used with other therapies.

If this was true this drug would be a VERY big deal in the HIV world. Most HIV-1 strains need to bind to the CCR5 receptor in CD4 T cells in order to establish infection, although they can later mutate inside the host so they don't need do. In fact, the only natural immunity ever observed to HIV is a very rare mutation to CCR5.

This drug has been languishing in trials for 10+ years. If it lived up to the narrative it should be front line HIV therapy. Something isn't adding up.

As far as trials with COVID-19 go, CCR5 is an important chemokine receptor involved in the immune response. So it appears the company is just trying out this drug as a general immune suppressant, as runaway immune response seems to be involved in pathology of serious COVID disease. But there are a lot of immune suppressant drugs, so I don't see why this one would be especially effective.

I wish you good luck with your gambool. But I just don't see it. I would guess this is a pump and dump scheme.

Edit: I just read today's press clippings from today and I guess the company is implying they have discovered a novel reason a CCR5 antagonist would effect SARS-COV2 directly. To date there is no proposed reason a CCR5 antagonist would directly effect the disease process that I know of. FWIW, CCR5 is expressed mainly on immune cells, which are not even cells that SARS-COV2 infects primarily, so I don't have a clue what mechanism they are claiming to have discovered. So I guess we will have to just wait and see what they have to say.

[Sanlmar]

Short the market via SPXU (Again) at 15.40.

I think the high is in at 2940. I’ll sell if the market sees 2940.5.

The test will come at 2850. I expect a bounce but expect it break south and if it does we will see 2700.

I was early and have had to pedal furiously to maintain my short.

I’m committed to the cause.

[Daly]

I don’t claim to understand the science but I trust some folks that I k is that do. This shit is doing things for patients with Rona that Gilead wishes it’s drug did and with zero side effects. This has a shot to go to the moon, like 1.5B company to 50B.

It’s a gamble - like go to the roulette wheel gamble as is all biotech.. want to be clear about that..... but if you got 4000 in chips in your portfolio this might be worth a shot.

I don't see it. The narrative is that the drug is a CCR5 antagonist that blocks HIV from entering cells, and doesn't have serious side effects and can be used with other therapies.

If this was true this drug would be a VERY big deal in the HIV world. Most HIV-1 strains need to bind to the CCR5 receptor in CD4 T cells in order to establish infection, although they can later mutate inside the host so they don't need do. In fact, the only natural immunity ever observed to HIV is a very rare mutation to CCR5.

This drug has been languishing in trials for 10+ years. If it lived up to the narrative it should be front line HIV therapy. Something isn't adding up.

As far as trials with COVID-19 go, CCR5 is an important chemokine receptor involved in the immune response. So it appears the company is just trying out this drug as a general immune suppressant, as runaway immune response seems to be involved in pathology of serious COVID disease. But there are a lot of immune suppressant drugs, so I don't see why this one would be especially effective.

I wish you good luck with your gambool. But I just don't see it. I would guess this is a pump and dump scheme.

Edit: I just read today's press clippings from today and I guess the company is implying they have discovered a novel reason a CCR5 antagonist would effect SARS-COV2 directly. To date there is no proposed reason a CCR5 antagonist would directly effect the disease process that I know of. FWIW, CCR5 is expressed mainly on immune cells, which are not even cells that SARS-COV2 infects primarily, so I don't have a clue what mechanism they are claiming to have discovered. So I guess we will have to just wait and see what they have to say.

I think in the days and weeks to come you going to hear about how this blocks the cytokine storm from happening as it relates to Convid 19. They are giving it to folks who are deaths doorstep and they are coming off ventilators 2 days later.

Like I said it’s a gamble, not just for my pocketbook but if this holds true it’s big for society.

[Sanlmar]

Tonight
Microsoft
Amazon - implied volatility $128

MGM - forward looking guidance should be lol. Folks are stupid though, so careful.


Special bonus
Remember all the new convention centers being built in Vegas?

[ErickAA]

I don't see it. The narrative is that the drug is a CCR5 antagonist that blocks HIV from entering cells, and doesn't have serious side effects and can be used with other therapies.

If this was true this drug would be a VERY big deal in the HIV world. Most HIV-1 strains need to bind to the CCR5 receptor in CD4 T cells in order to establish infection, although they can later mutate inside the host so they don't need do. In fact, the only natural immunity ever observed to HIV is a very rare mutation to CCR5.

This drug has been languishing in trials for 10+ years. If it lived up to the narrative it should be front line HIV therapy. Something isn't adding up.

As far as trials with COVID-19 go, CCR5 is an important chemokine receptor involved in the immune response. So it appears the company is just trying out this drug as a general immune suppressant, as runaway immune response seems to be involved in pathology of serious COVID disease. But there are a lot of immune suppressant drugs, so I don't see why this one would be especially effective.

I wish you good luck with your gambool. But I just don't see it. I would guess this is a pump and dump scheme.

Edit: I just read today's press clippings from today and I guess the company is implying they have discovered a novel reason a CCR5 antagonist would effect SARS-COV2 directly. To date there is no proposed reason a CCR5 antagonist would directly effect the disease process that I know of. FWIW, CCR5 is expressed mainly on immune cells, which are not even cells that SARS-COV2 infects primarily, so I don't have a clue what mechanism they are claiming to have discovered. So I guess we will have to just wait and see what they have to say.

I think in the days and weeks to come you going to hear about how this blocks the cytokine storm from happening as it relates to Convid 19. They are giving it to folks who are deaths doorstep and they are coming off ventilators 2 days later.

Like I said it’s a gamble, not just for my pocketbook but if this holds true it’s big for society.

Yeah. But there are probably 1000 drugs that are immunosuppressive. Why this particular one (that only antagonizes one chemokine receptor expressed on a limited number of cell types) should be so effective compared to all the others I have no clue.

[Sanlmar]

I know you’re SPY but I see an island top on Indu

[ErickAA]

I know you’re SPY but I see an island top on Indu

Stalling at the mountain top not doing me any good. We need to start going down the other side real fast. All my puts are toast pretty much except for some ones that expire May 29th, so lets get a move on down the other side.

[sonatine]

long on clx and aapl going into earnings.

gl all.

[ErickAA]

Damn, I had some 286 SPY puts that expire tomorrow that I have emotionally written off and moved on from. But now that shit has dropped to 287 so I have to sweat it again,



despite the fact I know there is going to be a massive rally tomorrow when Apple reports some fake numbers.

[Daly]

Damn, I had some 286 SPY puts that expire tomorrow that I have emotionally written off and moved on from. But now that shit has dropped to 287 so I have to sweat it again,



despite the fact I know there is going to be a massive rally tomorrow when Apple reports some fake numbers.

S&P shitting it’s pants a bit after hours.... you in the $$ if it holds

[ErickAA]

long on clx and aapl going into earnings.

gl all.

[Daly]

Short the market via SPXU (Again) at 15.40.

I think the high is in at 2940. I’ll sell if the market sees 2940.5.

The test will come at 2850. I expect a bounce but expect it break south and if it does we will see 2700.

And there we were. Futures hit rock bottom at 2853 and bounced. Going to be a bit of a battle at that level.

[Sanlmar]

Short the market via SPXU (Again) at 15.40.

I think the high is in at 2940. I’ll sell if the market sees 2940.5.

The test will come at 2850. I expect a bounce but expect it break south and if it does we will see 2700.

And there we were. Futures hit rock bottom at 2853 and bounced. Going to be a bit of a battle at that level.

Splendid timing

The day states open up. How about that. We both knew. Careful what you wish for.

I tried to get the jump and was rewarded with a laterfag


2850 was breached. It’ll prolly put up a fight

Fed needs a couple trillion more chips. It’ll get them.

Market will be on a respirator till then

[Daly]

And there we were. Futures hit rock bottom at 2853 and bounced. Going to be a bit of a battle at that level.

Splendid timing

The day states open up. How about that. We both knew. Careful what you wish for.

I tried to get the jump and was rewarded with a laterfag


2850 was breached. It’ll prolly put up a fight

Fed needs a couple trillion more chips. It’ll get them.

Market will be on a respirator till then

I’m not calling for a retest of the lows here. I do think the Fed has built in enough technical layers into the chart at this point that we won’t see under 2400 anytime soon. A drop to any one of the technical significant points between 2700-2400 which holds followed by a bounce back to 2940 will solidify the floor of where the market will trade. Guess what? The fed will make sure it happens.

Going to buy more SPXU at the open. I’ll hold until the drop tires. Then it’s sell and long via the corona stocks (CCL, MGM, DFS, BLMN) for me.